Ring Mountain Capital
ABBV icon

Ring Mountain Capital’s AbbVie ABBV Stock Holding History

Ring Mountain Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$494K Buy
1,888
+10
+0.5% +$2.56K 0.2% 60
2026
Q2 		$472K Sell
1,878
-7
-0.4% -$1.51K 0.2% 62
2026
Q1 		$410K Buy
1,885
+10
+0.5% +$2.22K 0.22% 60
2025
Q4 		$402K Buy
1,875
+15
+0.8% +$3.42K 0.21% 61
2025
Q3 		$431K Sell
1,860
-21
-1% -$4.28K 0.24% 56
2025
Q2 		$356K Buy
1,881
+10
+0.5% +$1.86K 0.22% 62
2025
Q1 		$392K Buy
1,871
+67
+4% +$13K 0.29% 54
2024
Q4 		$321K Buy
+1,804
New +$332K 0.21% 66

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Ring Mountain Capital's ABBV Position: Q3 2026 in Review

Ring Mountain Capital increased its AbbVie (ABBV) stake by 0.53% in Q3 2026, buying an estimated $2.56K and bringing the position to 1,888 shares worth $494K. The position accounts for 0.2% of the portfolio, ranked #60.

Ring Mountain Capital first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Ring Mountain Capital held 1,888 shares of AbbVie worth $494K as of Q3 2026.
  • Ring Mountain Capital bought 10 AbbVie shares in Q3 2026, an estimated $2.56K.
  • AbbVie made up 0.2% of Ring Mountain Capital's portfolio in Q3 2026, its #60 holding.
  • Ring Mountain Capital first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Ring Mountain Capital's 13F filing for Q3 2026, filed 13 Oct 2026.